SCHEMBL9311069

SCHEMBL9311069

CCc1nc(Cl)c(C(=O)OCOC(=O)C(C)(C)C)n1Cc1ccc2oc(-c3ccccc3-c3nnn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n3)c(Br)c2c1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9310042 0.94 AGTR1 (0.47) AGTR1
SCHEMBL9312400 0.94 AGTR1 (0.55) AGTR1
SCHEMBL9310227 0.92 AGTR1 (0.53) AGTR1
SCHEMBL9313679 0.91 AGTR1 (0.58) AGTR1
SCHEMBL9309381 0.91 AGTR1 (0.64) AGTR1
SCHEMBL9310233 0.89 AGTR1 (0.53) AGTR1
SCHEMBL9309889 0.88 AGTR1 (0.55) AGTR1
SCHEMBL9309231 0.88 AGTR1 (0.54) AGTR1
SCHEMBL9310870 0.87 AGTR1 (0.65) AGTR1
SCHEMBL9308989 0.87 AGTR1 (0.64) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5374646-A Treatment or prophylasix of hypertension and diseases associated with cognitive disorders GLAXO GROUP LIMITED (GB) 1994-12-20 US disclosed